BDBM248020 US9434724, 31

SMILES FC(F)Oc1ccc2c(c[nH]c2c1)C(=O)OCC12CCN(CC1)CC2

InChI Key InChIKey=GUKIAYZQCGKGEC-UHFFFAOYSA-N

Data  1 KI  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 248020   

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM248020(US9434724, 31)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 2D6(Human)
Alpharmagen

US Patent
LigandPNGBDBM248020(US9434724, 31)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 1A2(Human)
Alpharmagen

US Patent
LigandPNGBDBM248020(US9434724, 31)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 2C9(Human)
Alpharmagen

US Patent
LigandPNGBDBM248020(US9434724, 31)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 2C19(Human)
Alpharmagen

US Patent
LigandPNGBDBM248020(US9434724, 31)
Affinity DataIC50: 1.00E+4nMAssay Description:Protocol 2: Stock solution for NCEs (test articles) and standard inhibitors were prepared at a concentration of 20 mM in DMSO. Stock solutions were d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Rat)
Alpharmagen

US Patent
LigandPNGBDBM248020(US9434724, 31)
Affinity DataKi:  689nM ΔG°:  -8.74kcal/mole IC50: 788nMpH: 7.4 T: 2°CAssay Description:Protocol 1: The assay was conducted following the literature reference Meyer E. M., et al., Analysis of 3-(4-Hydroxy, 2-Methoxybenzylidene) Anabasein...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent